Drug to control bleeding in major spine surgery
Not Applicable
- Conditions
- Health Condition 1: null- Patients requiring Spine fusion surgery
- Registration Number
- CTRI/2012/01/002357
- Lead Sponsor
- AOSpine India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
•Patients aged 18 to 65 years
•Patients undergoing spinal surgery with expected significant blood loss
•Physical status ASA I to III inclusive
Exclusion Criteria
•Allergy to tranexamic acid
•Epilepsy
•Minimally invasive surgery
•Unwillingness to receive blood transfusion
•Known coagulopathy/hepatic disease
•Previous thromboembolic events
•Pregnancy
•Renal impairment
•Colour blindness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Measures <br/ ><br>â?¢% of patient transfusions <br/ ><br> <br/ ><br>â?¢Number of transfusions <br/ ><br>Secondary Measures <br/ ><br>â?¢Measured blood losses <br/ ><br>â?¢Morbidity <br/ ><br>Timepoint: 72 hours
- Secondary Outcome Measures
Name Time Method Measured blood losses <br/ ><br>oMorbidity <br/ ><br>oMortality <br/ ><br>oLength of stay in the hospital <br/ ><br>oCalculated blood losses <br/ ><br>Timepoint: 30 days